Laporan Laba Rugi (TTM)
Laporan Laba Rugi Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 16,673 | 16,659 | 16,284 | 16,324 | 16,231 | 15,878 | 15,557 | 15,433 | 15,141 | 14,925 | 14,925 | 15,017 | 15,273 | 15,846 | 16,004 | 16,290 | 16,772 | 16,544 | 16,616 | 16,628 |
| Change (%) | -0.08 | -2.25 | 0.25 | -0.57 | -2.17 | -2.02 | -0.80 | -1.89 | -1.43 | 0.00 | 0.62 | 1.70 | 3.75 | 1.00 | 1.79 | 2.96 | -1.36 | 0.44 | 0.07 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 9,038 | 8,933 | 8,743 | 8,672 | 8,639 | 8,284 | 8,101 | 8,056 | 7,889 | 7,952 | 8,110 | 8,200 | 8,272 | 8,200 | 8,169 | 8,227 | 8,413 | 8,481 | 8,447 | 8,381 |
| Change (%) | -1.16 | -2.13 | -0.81 | -0.38 | -4.11 | -2.21 | -0.56 | -2.07 | 0.80 | 1.99 | 1.11 | 0.88 | -0.87 | -0.38 | 0.71 | 2.26 | 0.81 | -0.40 | -0.78 | |
| % of Revenue | 54.21 | 53.62 | 53.69 | 53.12 | 53.23 | 52.17 | 52.07 | 52.20 | 52.10 | 53.28 | 54.34 | 54.60 | 54.16 | 51.75 | 51.04 | 50.50 | 50.16 | 51.26 | 50.84 | 50.40 |
| Gross Operating Profit | 7,635 | 7,726 | 7,541 | 7,652 | 7,592 | 7,594 | 7,456 | 7,377 | 7,252 | 6,973 | 6,815 | 6,817 | 7,001 | 7,646 | 7,835 | 8,063 | 8,359 | 8,063 | 8,169 | 8,247 |
| Change (%) | 1.19 | -2.39 | 1.47 | -0.78 | 0.03 | -1.82 | -1.06 | -1.69 | -3.85 | -2.27 | 0.03 | 2.70 | 9.21 | 2.47 | 2.91 | 3.67 | -3.54 | 1.31 | 0.95 | |
| % of Revenue | 45.79 | 46.38 | 46.31 | 46.88 | 46.77 | 47.83 | 47.93 | 47.80 | 47.90 | 46.72 | 45.66 | 45.40 | 45.84 | 48.25 | 48.96 | 49.50 | 49.84 | 48.74 | 49.16 | 49.60 |
| SG&A | 3,686 | 3,671 | 3,629 | 3,626 | 3,630 | 3,528 | 3,533 | 3,583 | 3,516 | 3,445 | 3,407 | 3,409 | 3,433 | 3,498 | 3,542 | 3,573 | 3,652 | 3,702 | 3,735 | 3,755 |
| Change (%) | -0.41 | -1.14 | -0.08 | 0.11 | -2.81 | 0.14 | 1.42 | -1.87 | -2.02 | -1.10 | 0.06 | 0.70 | 1.89 | 1.26 | 0.88 | 2.21 | 1.37 | 0.89 | 0.54 | |
| % of Revenue | 22.11 | 22.04 | 22.29 | 22.21 | 22.36 | 22.22 | 22.71 | 23.22 | 23.22 | 23.08 | 22.83 | 22.70 | 22.48 | 22.07 | 22.13 | 21.93 | 21.77 | 22.38 | 22.48 | 22.58 |
| R&D | 936 | 997 | 1,030 | 1,052 | 1,016 | 967 | 938 | 919 | 872 | 838 | 847 | 858 | 936 | 953 | 961 | 991 | 978 | 998 | 1,003 | 977 |
| Change (%) | 6.52 | 3.31 | 2.14 | -3.42 | -4.82 | -3.00 | -2.03 | -5.11 | -3.90 | 1.07 | 1.30 | 9.09 | 1.82 | 0.84 | 3.12 | -1.31 | 2.04 | 0.50 | -2.59 | |
| % of Revenue | 5.61 | 5.98 | 6.33 | 6.44 | 6.26 | 6.09 | 6.03 | 5.95 | 5.76 | 5.61 | 5.68 | 5.71 | 6.13 | 6.01 | 6.00 | 6.08 | 5.83 | 6.03 | 6.04 | 5.88 |
| OpEx | 13,640 | 13,604 | 13,417 | 13,413 | 13,267 | 12,799 | 12,562 | 12,489 | 12,281 | 12,263 | 12,429 | 12,536 | 12,705 | 12,666 | 12,663 | 12,805 | 13,042 | 13,172 | 13,195 | 13,128 |
| Change (%) | -0.26 | -1.37 | -0.03 | -1.09 | -3.53 | -1.85 | -0.58 | -1.67 | -0.15 | 1.35 | 0.86 | 1.35 | -0.31 | -0.02 | 1.12 | 1.85 | 1.00 | 0.17 | -0.51 | |
| % of Revenue | 81.81 | 81.66 | 82.39 | 82.17 | 81.74 | 80.61 | 80.75 | 80.92 | 81.11 | 82.16 | 83.28 | 83.48 | 83.19 | 79.93 | 79.12 | 78.61 | 77.76 | 79.62 | 79.41 | 78.95 |
| Operating Income | 3,033 | 3,055 | 2,867 | 2,911 | 2,964 | 3,079 | 2,995 | 2,944 | 2,860 | 2,662 | 2,496 | 2,481 | 2,568 | 3,180 | 3,341 | 3,485 | 3,730 | 3,372 | 3,421 | 3,500 |
| Change (%) | 0.73 | -6.15 | 1.53 | 1.82 | 3.88 | -2.73 | -1.70 | -2.85 | -6.92 | -6.24 | -0.60 | 3.51 | 23.83 | 5.06 | 4.31 | 7.03 | -9.60 | 1.45 | 2.31 | |
| % of Revenue | 18.19 | 18.34 | 17.61 | 17.83 | 18.26 | 19.39 | 19.25 | 19.08 | 18.89 | 17.84 | 16.72 | 16.52 | 16.81 | 20.07 | 20.88 | 21.39 | 22.24 | 20.38 | 20.59 | 21.05 |
| Interest Expense | -929 | -901 | -899 | -948 | -890 | -891 | -890 | -881 | -878 | -930 | -953 | -922 | -933 | -1,029 | -993 | -1,026 | -1,011 | -1,002 | -989 | -976 |
| Change (%) | -3.01 | -0.22 | 5.45 | -6.12 | 0.11 | -0.11 | -1.01 | -0.34 | 5.92 | 2.47 | -3.25 | 1.19 | 10.29 | -3.50 | 3.32 | -1.46 | -0.89 | -1.30 | -1.31 | |
| % of Revenue | -5.57 | -5.41 | -5.52 | -5.81 | -5.48 | -5.61 | -5.72 | -5.71 | -5.80 | -6.23 | -6.39 | -6.14 | -6.11 | -6.49 | -6.20 | -6.30 | -6.03 | -6.06 | -5.95 | -5.87 |
| Net Income | -4,031 | -3,990 | -3,982 | -3,915 | 726 | 417 | -615 | -1,054 | -1,291 | -2,446 | -1,711 | -2,350 | -2,336 | -559 | -478 | -453 | -959 | -1,639 | -1,286 | -157 |
| Change (%) | -1.02 | -0.20 | -1.68 | -118.54 | -42.56 | -247.48 | 71.38 | 22.49 | 89.47 | -30.05 | 37.35 | -0.60 | -76.07 | -14.49 | -5.23 | 111.70 | 70.91 | -21.54 | -87.79 | |
| % of Revenue | -24.18 | -23.95 | -24.45 | -23.98 | 4.47 | 2.63 | -3.95 | -6.83 | -8.53 | -16.39 | -11.46 | -15.65 | -15.29 | -3.53 | -2.99 | -2.78 | -5.72 | -9.91 | -7.74 | -0.94 |
Source: Capital IQ
